Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Ernexa Therapeutics Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Ernexa Therapeutics Inc tiene un total de activos de $5, una ganancia neta loss de $-44

Question 2

¿Cuáles son los ratios financieros clave para ERNA?

Accepted Answer

El ratio corriente de Ernexa Therapeutics Inc es 1.66, el margen neto es 0, las ventas por acción son $0.

Question 3

¿Cómo se desglosan los ingresos de Ernexa Therapeutics Inc por segmento o geografía?

Accepted Answer

Ernexa Therapeutics Inc largest revenue segment is Cellular Therapies, at a revenue of 582,000 in the most earnings release.For geography, United States is the primary market for Ernexa Therapeutics Inc, at a revenue of 582,000.

Question 4

¿Es rentable Ernexa Therapeutics Inc?

Accepted Answer

no, según los últimos estados financieros, Ernexa Therapeutics Inc tiene una ganancia neta loss de $-44

Question 5

¿Tiene Ernexa Therapeutics Inc alguna deuda?

Accepted Answer

yes, Ernexa Therapeutics Inc tiene una deuda de 3

Question 6

¿Cuántas acciones en circulación tiene Ernexa Therapeutics Inc?

Accepted Answer

Ernexa Therapeutics Inc tiene un total de acciones en circulación de 3.42

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	5
Revenue Growth (YoY)	--	--	--	--	-100%	-74%
Cost of Revenue	0	0	0	--	--	2
Gross Profit	0	0	0	--	--	2
Selling, General & Admin	7	13	14	16	14	6
Research & Development	4	4	5	10	12	2
Operating Expenses	33	17	20	27	27	8
Other Non Operating Income (Expenses)	-5	0	0	9	0	2
Pretax Income	-43	-44	-21	-24	-122	-4
Income Tax Expense	0	0	0	0	0	0
Net Income	-43	-44	-21	-24	-122	-4
Net Income Growth	87%	110%	-13%	-80%	2,950%	100%
Shares Outstanding (Diluted)	5.17	0.9	0.35	0.2	0.14	0
Shares Change (YoY)	1,336%	157%	74%	41%	2,847%	2%
EPS (Diluted)	-8.44	-48.97	-61.2	-120.94	-848.98	-907.78
EPS Growth	-87%	-20%	-49%	-86%	-6%	111%
Free Cash Flow	-14	-16	-20	-21	-23	-4
Free Cash Flow Per Share	-2.7	-17.58	-56.44	-103.24	-159.27	-816.32
Gross Margin	0%	0%	0%	--	--	40%
Operating Margin	0%	0%	0%	0%	0%	-100%
Profit Margin	0%	0%	0%	0%	0%	-80%
Free Cash Flow Margin	0%	0%	0%	0%	0%	-80%
EBITDA	-32	-17	-20	-27	-27	-4
EBITDA Margin	0%	0%	0%	0%	0%	-80%
D&A For EBITDA	0	0	0	0	0	1
EBIT	-32	-17	-20	-27	-27	-5
EBIT Margin	0%	0%	0%	0%	0%	-100%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Ernexa Therapeutics Inc (ERNA) Price

ERNA Stock Price Chart

ERNA Income

Follow-Up Questions